GBp 63.5
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.23 Million | -5.14 Million | -7.22 Million | -3.38 Million | -3.23 Million | -4.57 Million |
Net Income | -3.16 Million | -7.22 Million | -8.51 Million | -5.11 Million | -5.88 Million | -5.37 Million |
Depreciation & Amortization | 836.4 Thousand | 790.27 Thousand | 512.06 Thousand | 379.92 Thousand | 124.86 Thousand | 786.72 Thousand |
Deferred income taxes | -144.19 Thousand | 84.29 Thousand | 214.75 Thousand | 426.55 Thousand | 415.91 Thousand | 49.97 Thousand |
Stock-based compensation | 217.92 Thousand | 1.47 Million | 1.6 Million | 376.92 Thousand | 2992.00 | 215.13 Thousand |
Change in working capital | -610.25 Thousand | -379.39 Thousand | -1.05 Million | 521.6 Thousand | 2.09 Million | -276.12 Thousand |
Other non-cash items | 2.99 Million | 106.28 Thousand | 18.92 Thousand | 25.31 Thousand | 15.73 Thousand | 22.55 Thousand |
Investing Cash Flow | -236.46 Thousand | -1.14 Million | -1.5 Million | -1.08 Million | -1.42 Million | -910.19 Thousand |
Investments in PPE | -236.46 Thousand | -1.13 Million | -1.5 Million | -1.08 Million | -638.78 Thousand | -595.12 Thousand |
Acquisitions | - | - | 50.00 | - | -788.76 Thousand | -315.07 Thousand |
Investment purchases | - | -4999.00 | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -226.89 Thousand | -1.1 Million | -1.43 Million | -1.05 Million | -596.46 Thousand | -593.63 Thousand |
Financing Cash Flow | 1.79 Million | 3.95 Million | 11.75 Million | 4.86 Million | 4.65 Million | 4.93 Million |
Debt repayment | -840.27 Thousand | -3263.00 | -28.86 Thousand | -150 Thousand | -23.46 Thousand | -144.24 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 954.13 Thousand | 2.06 Million | 11.8 Million | 4.93 Million | 3.86 Million | 5.2 Million |
Other Financing Activities | 884.93 Thousand | 1.89 Million | -18.92 Thousand | 86.14 Thousand | 816.05 Thousand | -120.58 Thousand |
Accounts receivables | -863.43 Thousand | -80.15 Thousand | -541.69 Thousand | -413.02 Thousand | -496.93 Thousand | 28.19 Thousand |
Accounts payables | 397.38 Thousand | -383.54 Thousand | -841.33 Thousand | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -144.19 Thousand | 84.29 Thousand | 323.97 Thousand | 934.62 Thousand | 2.58 Million | - |
Cash at beginning of period | 1.35 Million | 3.68 Million | 654.79 Thousand | 256.94 Thousand | 261.6 Thousand | 815.04 Thousand |
Cash at end of period | 677.85 Thousand | 1.35 Million | 3.68 Million | 654.79 Thousand | 256.94 Thousand | 261.6 Thousand |
Capital Expenditure | -236.46 Thousand | -1.13 Million | -1.5 Million | -1.08 Million | -638.78 Thousand | -595.12 Thousand |
Effect of forex changes on cash | - | - | - | - | - | -3.00 |
Net cash flow / Change in cash | -674.36 Thousand | -2.33 Million | 3.03 Million | 397.84 Thousand | -4662.00 | -553.43 Thousand |
Free Cash Flow | -2.46 Million | -6.28 Million | -8.72 Million | -4.47 Million | -3.87 Million | -5.17 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -716.89 Thousand | -716.89 Thousand | -3.16 Million | -752.15 Thousand | -752.15 Thousand | -1.66 Million |
Depreciation & Amortization | 190.33 Thousand | 190.33 Thousand | 836.4 Thousand | 11.22 Thousand | 11.22 Thousand | 446.86 Thousand |
Deferred income taxes | - | - | -144.19 Thousand | -144.19 Thousand | - | -1.58 Million |
Stock-based compensation | 42.03 Thousand | 42.03 Thousand | 217.92 Thousand | -11.88 Thousand | -11.88 Thousand | 120.84 Thousand |
Change in working capital | 94.94 Thousand | 94.94 Thousand | -610.25 Thousand | -120.9 Thousand | -120.9 Thousand | -649.2 Thousand |
Other non-cash items | 472.18 Thousand | 472.18 Thousand | 2.99 Million | 420.14 Thousand | 420.14 Thousand | 2.04 Million |
Investing Cash Flow | -49.85 Thousand | -49.85 Thousand | -236.46 Thousand | -57.77 Thousand | -57.77 Thousand | -120.9 Thousand |
Investments in PPE | -6245.00 | -6245.00 | -236.46 Thousand | -978.00 | -978.00 | -120.9 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -43.61 Thousand | -43.61 Thousand | -226.89 Thousand | -56.8 Thousand | -56.8 Thousand | -56.64 Thousand |
Financing Cash Flow | 29.83 Thousand | 29.83 Thousand | 1.79 Million | 511.46 Thousand | 511.46 Thousand | 732.45 Thousand |
Debt repayment | -57.35 Thousand | - | -840.27 Thousand | -107.82 Thousand | - | -732.45 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 34.16 Thousand | - | 954.13 Thousand | 954.13 Thousand | - | - |
Other Financing Activities | 29.83 Thousand | 29.83 Thousand | 884.93 Thousand | 511.46 Thousand | 511.46 Thousand | 351.14 Thousand |
Accounts receivables | 94.94 Thousand | 94.94 Thousand | -863.43 Thousand | -120.9 Thousand | -120.9 Thousand | -621.62 Thousand |
Accounts payables | 706.46 Thousand | - | 397.38 Thousand | 345.94 Thousand | - | 51.44 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -67.63 Thousand | - | -144.19 Thousand | -65.17 Thousand | - | -79.02 Thousand |
Cash at beginning of period | 677.85 Thousand | - | 1.35 Million | 677.62 Thousand | - | 1.35 Million |
Cash at end of period | 803.01 Thousand | 62.58 Thousand | 677.85 Thousand | 677.85 Thousand | 117.00 | 677.62 Thousand |
Capital Expenditure | -6245.00 | -6245.00 | -236.46 Thousand | -978.00 | -978.00 | -120.9 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 125.15 Thousand | 62.58 Thousand | -674.36 Thousand | 233.00 | 117.00 | -674.59 Thousand |
Free Cash Flow | 76.35 Thousand | 76.35 Thousand | -2.46 Million | -454.54 Thousand | -454.54 Thousand | -1.4 Million |
FORE
7399
603339
KLIN
000875
CHCT